Gene · 3714
Papers2,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sociodemographic Factors Associated with Knowledge About Management of Cleft Lip and Palate Patients in Peruvian Dental Students: A Logistic Regression Analysis. | Adv Med Educ Pract | 2023 | 38028374 | PubTator, text mining | PubMed |
| Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2. | Cell Death Dis | 2023 | 38016947 | PubTator, text mining | PubMed |
| Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis. | Viruses | 2023 | 38005929 | PubTator, text mining | PubMed |
| Notch Signaling Regulates the Function and Phenotype of Dendritic Cells in Helicobacter pylori Infection. | Microorganisms | 2023 | 38004829 | PubTator, text mining | PubMed |
| Essential Role of Granulosa Cell Glucose and Lipid Metabolism on Oocytes and the Potential Metabolic Imbalance in Polycystic Ovary Syndrome. | Int J Mol Sci | 2023 | 38003436 | PubTator, text mining | PubMed |
| Optimization of a Three-Dimensional Culturing Method for Assessing the Impact of Cisplatin on Notch Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC). | Cancers (Basel) | 2023 | 38001580 | PubTator, text mining | PubMed |
| Genista tridentata Phytochemical Characterization and Biological Activities: A Systematic Review. | Biology (Basel) | 2023 | 37997986 | PubTator, text mining | PubMed |
| γδ T cells: origin and fate, subsets, diseases and immunotherapy. | Signal Transduct Target Ther | 2023 | 37989744 | PubTator, text mining | PubMed |
| Tryptanthrin inhibits tumor angiogenesis via Notch/Dll4 signaling pathway in zebrafish. | Transl Cancer Res | 2023 | 37969390 | PubTator, text mining | PubMed |
| Langerhans cell histiocytosis: current advances in molecular pathogenesis. | Front Immunol | 2023 | 37965340 | PubTator, text mining | PubMed |
| Developments in Genetics: Better Management of Ovarian Cancer Patients. | Int J Mol Sci | 2023 | 37958970 | PubTator, text mining | PubMed |
| Advances in Biomarkers for Diagnosis and Treatment of ARDS. | Diagnostics (Basel) | 2023 | 37958192 | PubTator, text mining | PubMed |
| Construction and validation of a novel angiogenesis pattern to predict prognosis and immunotherapy efficacy in colorectal cancer. | Aging (Albany NY) | 2023 | 37938164 | PubTator, text mining | PubMed |
| Astrogliosis in multiple sclerosis and neuro-inflammation: what role for the notch pathway? | Front Immunol | 2023 | 37936690 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37929034 | PubTator, text mining | PubMed |
| The critical role of γ-secretase and its inhibitors in cancer and cancer therapeutics. | Int J Biol Sci | 2023 | 37928268 | PubTator, text mining | PubMed |
| Bioinformatics and Systems Biology Approach to Identify the Pathogenetic Link between Heart Failure and Sarcopenia. | Arq Bras Cardiol | 2023 | 37909603 | PubTator, text mining | PubMed |
| Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead. | Int J Mol Sci | 2023 | 37894928 | PubTator, text mining | PubMed |
| DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer. | Biomedicines | 2023 | 37893184 | PubTator, text mining | PubMed |
| Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription. | Cancer Res Commun | 2023 | 37882668 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3714/papers?page=7